A Few Bright Spots In Dr. Reddy’s Laboratories Ltd. ADR (NYSE: RDY)

Dr. Reddy’s Laboratories Ltd. ADR (NYSE:RDY) currently has a daily average trading volume of 1.30M but it saw 2361510 shares traded in last market. With a market cap of 12.76B USD, the company’s current market price of $15.32 came rising about 0.39 while comparing to the previous closing price of $15.26. In past 52 weeks, the stock remained buoying in the range of price level as high as $16.89 and as low as $13.43. In the recent trading on the day, stock has struck highest price mark of $15.175 while lowest mark touched by it was $15.33.

Taking a look at 20-day trading activity of Dr. Reddy’s Laboratories Ltd. ADR (RDY) gives us an average price of $15.38, while its current price level is -9.31% below from 52-week high level whereas it is 14.06% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $14.83 while that of 200 days or SMA-200 reads an average of $15.17. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.56% during that period while stretching the period over a month that decreases to 1.38%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 52.19 which implies that the stock is in neutral territory.

Over the week, RDY’s stock price is moving -2.23% down while it is 6.39% when we observe its performance for the past one month. Year-to-date it is -2.98% down and over the past year, the stock is showing an upside performance of 10.41%.

Currently, Dr. Reddy’s Laboratories Ltd. ADR’s total number of outstanding shares is 834.38M. Company’s return on investment (ROI) stands at 17.14% and return on equity (ROE) at 19.12%. It has a price to earnings ratio (P/E ratio) of 19.97 while having a 18.85 of forward P/E ratio. Stock’s beta reads 0.51. Stock has a price to book (P/B) ratio of 3.51 while price to sale or P/S ratio amounts to 3.55. Its return on asset (ROA) is 13.14% on average.